Sironax

About:

Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.

Website: https://www.sironax.com.cn/

Top Investors: Temasek Holdings, F-Prime Capital, ARCH Venture Partners, Invus, Gaorong Capital

Description:

Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases. The company is focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. They aim to shift the treatment paradigm for age-related degenerative disease to improve the lives of millions of patients and their families around the world. Sironax was founded in 2017 and is based in Beijing, China.